These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation. Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner. Lavie M; Dubuisson J; Belouzard S J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein. Matveev EV; Ponomarev GV; Kazanov MD Microbiol Spectr; 2024 Feb; 12(2):e0353023. PubMed ID: 38189333 [TBL] [Abstract][Full Text] [Related]
5. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling. Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526 [TBL] [Abstract][Full Text] [Related]
7. Reactive Centre Loop Mutagenesis of SerpinB3 to Target TMPRSS2 and Furin: Inhibition of SARS-CoV-2 Cell Entry and Replication. Singh S; O'Reilly S; Gewaid H; Bowie AG; Gautier V; Worrall DM Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293378 [TBL] [Abstract][Full Text] [Related]
8. Metalloproteinase-Dependent and TMPRSS2-Independent Cell Surface Entry Pathway of SARS-CoV-2 Requires the Furin Cleavage Site and the S2 Domain of Spike Protein. Yamamoto M; Gohda J; Kobayashi A; Tomita K; Hirayama Y; Koshikawa N; Seiki M; Semba K; Akiyama T; Kawaguchi Y; Inoue JI mBio; 2022 Aug; 13(4):e0051922. PubMed ID: 35708281 [TBL] [Abstract][Full Text] [Related]
9. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease. Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162 [TBL] [Abstract][Full Text] [Related]
10. ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells. Heindl MR; Rupp A-L; Schwerdtner M; Bestle D; Harbig A; De Rocher A; Schmacke LC; Staker B; Steinmetzer T; Stein DA; Moulton HM; Böttcher-Friebertshäuser E J Virol; 2024 Apr; 98(4):e0010224. PubMed ID: 38470058 [TBL] [Abstract][Full Text] [Related]
11. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843 [TBL] [Abstract][Full Text] [Related]
12. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Peacock TP; Goldhill DH; Zhou J; Baillon L; Frise R; Swann OC; Kugathasan R; Penn R; Brown JC; Sanchez-David RY; Braga L; Williamson MK; Hassard JA; Staller E; Hanley B; Osborn M; Giacca M; Davidson AD; Matthews DA; Barclay WS Nat Microbiol; 2021 Jul; 6(7):899-909. PubMed ID: 33907312 [TBL] [Abstract][Full Text] [Related]
13. Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin. Tang T; Jaimes JA; Bidon MK; Straus MR; Daniel S; Whittaker GR ACS Infect Dis; 2021 Feb; 7(2):264-272. PubMed ID: 33432808 [TBL] [Abstract][Full Text] [Related]
14. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein. Kleine-Weber H; Elzayat MT; Hoffmann M; Pöhlmann S Sci Rep; 2018 Nov; 8(1):16597. PubMed ID: 30413791 [TBL] [Abstract][Full Text] [Related]
15. Study of protease-mediated processes initiating viral infection and cell-cell viral spreading of SARS-CoV-2. Thaingtamtanha T; Baeurle SA J Mol Model; 2022 Jul; 28(8):224. PubMed ID: 35854129 [TBL] [Abstract][Full Text] [Related]
16. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19. Li K; Meyerholz DK; Bartlett JA; McCray PB mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553 [TBL] [Abstract][Full Text] [Related]
17. A second functional furin site in the SARS-CoV-2 spike protein. Zhang Y; Zhang L; Wu J; Yu Y; Liu S; Li T; Li Q; Ding R; Wang H; Nie J; Cui Z; Wang Y; Huang W; Wang Y Emerg Microbes Infect; 2022 Dec; 11(1):182-194. PubMed ID: 34856891 [TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation. Yu S; Zheng X; Zhou B; Li J; Chen M; Deng R; Wong G; Lavillette D; Meng G Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34930824 [TBL] [Abstract][Full Text] [Related]
20. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin. Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]